Beppino C. Giovanella, Ph.D.
Zhisong Cao, Ph.D.
Associate Laboratory Director, Chief Chemist
Deputy Director/Clinical Operations Officer
Constantine Markides, Ph.D.
Xing (Lucy) Liu, Ph.D.
Research Scientist, Analytical Chemistry
Anthony (Tony) Kozielski
Section Supervisor, Chemotherapy
Yang Wang, Ph.D.
Research Scientist, Synthetic Chemistry
Tissue Culture Supervisor
Edward (Eddie) Petry, Jr.
Vivarium Section Supervisor
CHRISTUS Stehlin Foundation for Cancer Research will join CHRISTUS St. Catherine and CHRISTUS St. John in a new partnership with Houston Methodist.
There are currently 13.7 million cancer survivors in the United States and the number is expected to rise by 31 percent to 18 million by 2022, according to a new report. >> Click article title for more.
“I think it has been too easy to overlook what a progressive physician Dr. John Stehlin was, and how pivotal he was for the humane treatment of individuals with cancer. He changed the cancer landscape forever, and his work continues with the research the CHRISTUS Stehlin Foundation is doing today.”
Dr. Peter de Ipolyi,